FACULTY: Science
DEPARTMENT: Biochemistry and Molecular Biology
NAME OF STAFF: Marcel Moyeh Nyuylam
E-mail: marcel.moyeh@ubuea.cm
Secondary E-mail: marcel7139@yahoo.com
Tel: +237 677056354
GRADE: Assistant Lecturer
BRIEF EDUCATIONAL BACKGROUND
BSc in Biochemistry from the University of Buea in 2000
MSc in Biochemistry from the University of Buea in 2005
Registered for PhD program in Biochemistry at the University of Yaounde 1
RESEARCH INTEREST AREA
Antimalarial drug studies in Cameroon (Safety and Efficacy)
MASTER DESSERTATIONS SUPERVISED
None
PhD THESES SUPERVISED
None
Publications
Akindeh M Nji , Innocent M Ali , Marcel N Moyeh , Eric-Oliver Ngongang , Aristide M Ekollo , Jean-Paul Chedjou , Valentine N Ndikum, , Marie S Evehe, , GuenterFroeschl, , Christian Heumann, Ulrich Mansmann, OlumideOgundahunsi and Wilfred F Mbacham. Randomized non-inferiority and safety trial of dihydroartemisin-piperaquine and artesunate-amodiaquine versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Cameroonian children. Malaria Journal(2015) 14:27. DOI 10.1186/s12936-014-0521-2
Personal Summary
Marcel Moyeh Nyuylam is an Assistant lecturer of Biochemistry and Molecular Biology in the Faculty of Science. He is a young scientist interested in malaria research geared towards evaluating the safety and efficacy of antimalarial drugs
His present research work for which he is pursuing a PhD is aimed at determining the efficacy and safety of artemisinin based antimalarial drug combinations in the South West Region as treatment guidelines evolved from single therapy through non-Artemisinin based combination therapy to Artemisinin based Combination Therapy. This project that started in 2003 will equally evaluate the evolution of molecular markers of resistance to antimalarials commonly used in the South West region of Cameroon. The outcome of his research work will enable policy makers decide on the choice of antimalarial drug to be used as first and second line drug. It will also serve as an alarm clock to alert policy makers to start considering alternative options when the drug in use is beginning to fail.
His research work has received funding from international funders through his supervisor Prof Wilfred Fon Mbacham. Funders for the project include the Gates and Melinder Foundation through the London School of hygiene and tropical Medicine, the international atomic energy agency and WHO/TDR
